TY - JOUR
T1 - Update on Transcatheter Aortic Valve Replacement
AU - Randall, Morgan H.
AU - Bavry, Anthony A.
N1 - Funding Information:
No funding or sponsorship was received for this study or publication of this article. All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published. Anthony Bavry is a member of the journal’s Editorial Board. Morgan Randall has nothing to disclose. This article is based on previously conducted studies and does not contain any studies with human participants or animals performed by any of the authors. This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
Publisher Copyright:
© 2020, The Author(s).
PY - 2020/6/1
Y1 - 2020/6/1
N2 - Transcatheter aortic valve replacement (TAVR) is a minimally invasive approach to treat symptomatic severe aortic stenosis. The patient populations that have been shown to benefit from this procedure continue to grow with time. Techniques and technology in TAVR persistently advance with a continued trend toward improved outcomes for patients. In this review, we highlight the advances in vascular access, TAVR valve design, progress in reducing procedural complications, and emerging evidence in the field.
AB - Transcatheter aortic valve replacement (TAVR) is a minimally invasive approach to treat symptomatic severe aortic stenosis. The patient populations that have been shown to benefit from this procedure continue to grow with time. Techniques and technology in TAVR persistently advance with a continued trend toward improved outcomes for patients. In this review, we highlight the advances in vascular access, TAVR valve design, progress in reducing procedural complications, and emerging evidence in the field.
KW - Alternative transcatheter aortic valve access
KW - Transcatheter aortic valve replacement (TAVR)
KW - Transcatheter aortic valve replacement complications
KW - Transcatheter aortic valve review
UR - http://www.scopus.com/inward/record.url?scp=85096744924&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85096744924&partnerID=8YFLogxK
U2 - 10.1007/s40119-020-00167-6
DO - 10.1007/s40119-020-00167-6
M3 - Review article
C2 - 32112370
AN - SCOPUS:85096744924
SN - 2193-8261
VL - 9
SP - 75
EP - 84
JO - Cardiology and Therapy
JF - Cardiology and Therapy
IS - 1
ER -